NEW Delhi: India announced Tuesday a partial lifting of a fresh export ban on a malaria drug seen as a potential coronavirus treatment, after US President Donald Trump hinted at "retaliation".
Citing domestic needs, India banned on Saturday exports of hydroxychloroquine which has shown early promise against COVID-19 in small-scale studies in France and China. India is the world’s largest producer and exporter of the drug, according to media reports.
Global stocks are however limited and Trump said that he had pressed Indian Prime Minister Narendra Modi this weekend to expedite shipments, hinting at consequences otherwise. "If he doesn’t allow it to come out, he doesn’t allow it to come out, that would be okay, but of course, there may be retaliation, why wouldn’t there be?" Trump said on Monday.
In body camera video released on Thursday by the Canton Police Department, officers are seen apprehending the man
Voter turnout around the halfway mark was 39%, an Election Commission spokesperson said
The U.N. has said nearly 25 million people, half of Sudan’s population, need aid and some 8 million have fled their...
The influx of weapons could improve Kyiv’s chances of averting a major Russian breakthrough in the east
The Perlmutters gave at least $21 million to America First Action Inc in 2020
Twenty other defendants were handed prison sentences ranging from 4 years to life